Apollo Hospitals Launches 76th Facility: 400-Bed Smart Hospital in Hyderabad Financial District

IMT News Desk
IMT News Desk
· 2 min read
Apollo Hospitals launches 76th facility, a 400-bed smart hospital in Hyderabad Financial District with AI workflows, uMR Omega MRI, and advanced ICUs

Apollo Hospitals Group inaugurated its 76th hospital, a 400-bedded next-generation smart facility in Hyderabad’s Financial District, strengthening India’s technology-led healthcare infrastructure. The hospital was launched by Telangana Chief Minister Revanth Reddy, alongside Health Minister Sri Damodar Rajanarsimha and MLA Sri Arekapudi Gandhi.

The digitally integrated facility features AI-enabled scheduling, real-time clinical connectivity, Arthrex Pano Scope for minimally invasive procedures, VALD technology for rehabilitation assessment, and uMR Omega 3.0T MRI with AI workflows for faster, noise-reduced imaging. Advanced ICUs with dedicated nursing and biophilic design enhance patient comfort across age groups.

Dr Prathap C Reddy, Founder & Chairman, Apollo Hospitals Group, said: “When we build a hospital, we are building far more than infrastructure; we are building hope. This institution is rooted in gratitude for the countless lives that have allowed us to learn, serve, and grow.”

Dr Sangita Reddy, Joint Managing Director, added: “The 76th hospital is not just a milestone – it is a declaration that our mission of providing quality healthcare to all will continue. With our new smart hospital in Hyderabad’s Financial District, we are reaffirming India’s leadership in building next-generation healthcare systems.”

Upasana Konidela, Vice Chairperson CSR, announced 10,000 free Sunday health screenings for the Nanakramguda community (call 040-23606666). Tejesvi Veerepalli, Regional CEO – AP/Telangana, highlighted the hospital’s ‘golden hour’ emergency response via connected ambulances and 1066 helpline.

The facility reinforces Apollo’s legacy of clinical excellence, making world-class care accessible while positioning Hyderabad as a global medical destination.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk